Cargando…
A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is a remarkably heterogeneous and aggressive disease with dismal prognosis of patients. The identification of promising prognostic biomarkers might enable effective diagnosis and treatment of LUAD. Aberrant activation of epithelial-mesenchymal transition (EMT) is required...
Autores principales: | Cui, Yimeng, Wang, Xin, Zhang, Lei, Liu, Wei, Ning, Jinfeng, Gu, Ruixue, Cui, Yaowen, Cai, Li, Xing, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521574/ https://www.ncbi.nlm.nih.gov/pubmed/36185284 http://dx.doi.org/10.3389/fonc.2022.974614 |
Ejemplares similares
-
Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer
por: Zhong, Weilong, et al.
Publicado: (2023) -
Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II
por: Zhong, Weilong, et al.
Publicado: (2023) -
Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023) -
Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022) -
LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype
por: Cao, Canhui, et al.
Publicado: (2020)